Aclaris Therapeutics to Participate in Upcoming Investor Conferences
February 22 2021 - 7:00AM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
biopharmaceutical company focused on developing novel drug
candidates for immuno-inflammatory diseases, today announced that
Dr. Neal Walker, President and CEO of Aclaris, will present a
company overview at the following upcoming virtual investor
conferences:
- H.C. Wainwright Global Life Sciences
Conference. Tuesday, March 9, 2021 at 7:00 a.m. ET.
Management will be available March 9th and 10th throughout the day
for virtual one-on-one meetings.
- Oppenheimer 31st Annual Healthcare Conference.
Tuesday, March 16, 2021 at 10:00 a.m. ET. Management will be
available March 16th throughout the day for virtual one-on-one
meetings.
A live audio webcast of each presentation may be accessed
through the “Events” page of the “Investors” section of Aclaris’
website, www.aclaristx.com. Each webcast will be archived for at
least 30 days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates to address
the needs of patients with immuno-inflammatory diseases who lack
satisfactory treatment options. The company has a multi-stage
portfolio of drug candidates powered by a robust R&D engine
exploring protein kinase regulation. For additional information,
please visit www.aclaristx.com.
Aclaris Contact
investors@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Sep 2023 to Sep 2024